If Congress starts reviewing licensing deals, diligence gets a documentation problem
Headline from KRDO
Historically, national security reviews were not a topic of conversation in biotech licensing deals. Things are changing. The bipartisan Biotech Investment National Security Act of 2026 would amend the COINS Act by adding biotechnology as a covered sector, expand reviewable transactions to include l…
KRDO's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
Historically, national security reviews were not a topic of conversation in biotech licensing deals. Things are changing. The bipartisan Biotech Investment National Security Act of 2026 would amend the COINS Act by adding biotechnology as a covered sector, expand reviewable transactions to include l…
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
If Congress starts reviewing licensing deals, diligence gets a documentation problem | Since Then
